The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait

References

• Statius van Eps LW, Pinedo-Veels C, de Vries GH, et al. Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies. Lancet. 1970;1(7644):450–452.
   PubMed Web of Science ®Google Scholar
• Becker AM. Sickle cell nephropathy: challenging the conventional wisdom. Pediatr Nephrol. 2011.
   PubMed Web of Science ®Google Scholar
• Ataga KI, Derebail VK, Archer DR. The glomerulopathy of sickle cell disease. Am J Hematol. 2014;89(9):907–914.
   PubMed Web of Science ®Google Scholar
• Nath KA, Grande JP, Croatt AJ, et al. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol. 2005;166(4):963–972.
   PubMed Web of Science ®Google Scholar
• Nath KA, Hebbel RP. Sickle cell disease: renal manifestations and mechanisms. Nat Rev Nephrol. 2015;11(3):161–171.
   PubMed Web of Science ®Google Scholar
• de Jong PE, Statius van Eps LW. Sickle cell nephropathy: new insights into its pathophysiology. Kidney Int. 1985;27(5):711–717.
   PubMed Web of Science ®Google Scholar
• Nath KA, Grande JP, Haggard JJ, et al. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol. 2001;158(3):893–903.
   PubMed Web of Science ®Google Scholar
• Ataga KI, Brittain JE, Moore D, et al. Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1. Eur J Haematol. 2010;85(3):257–263.
   PubMed Web of Science ®Google Scholar
• Ramzy D, Rao V, Tumiati LC, et al. Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation. 2006;114(1 Suppl):I319–26.
   PubMedGoogle Scholar
• De Miguel C, Speed JS, Kasztan M, et al. Endothelin-1 and the kidney: new perspectives and recent findings. Curr Opin Nephrol Hypertens. 2016;25(1):35–41.
   PubMed Web of Science ®Google Scholar
• Heimlich JB, Speed JS, O’Connor PM, et al. Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species. Br J Pharmacol. 2016;173(2):386–395.
   PubMed Web of Science ®Google Scholar
• Kasztan M, Fox BM, Speed JS, et al. Long-term endothelin-a receptor antagonism provides robust renal protection in humanized sickle cell disease mice. J Am Soc Nephrol. 2017.
   PubMed Web of Science ®Google Scholar
• Ataga KI, Derebail VK, Caughey M, et al. Albuminuria is associated with endothelial dysfunction and elevated plasma endothelin-1 in sickle cell anemia. PLoS One. 2016;11(9):e0162652.
   PubMed Web of Science ®Google Scholar
• Eshbach ML, Kaur A, Rbaibi Y, et al. Hemoglobin inhibits albumin uptake by proximal tubule cells: implications for sickle cell disease. Am J Physiol Cell Physiol. 2017;312(6):C733–C740.
   PubMed Web of Science ®Google Scholar
• Lusco MA, Fogo AB, Najafian B, et al. AJKD atlas of renal pathology: sickle cell nephropathy. Am J Kidney Dis. 2016;68(1):e1–3.
   PubMed Web of Science ®Google Scholar
• Day TG, Drasar ER, Fulford T, et al. Association between hemolysis and albuminuria in adults with sickle cell anemia. Haematologica. 2012;97(2):201–205.
   PubMed Web of Science ®Google Scholar
• Hamideh D, Raj V, Harrington T, et al. Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia. Pediatr Nephrol. 2014;29(10):1997–2003.
   PubMed Web of Science ®Google Scholar
• Saraf SL, Zhang X, Kanias T, et al. Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br J Haematol. 2014;164(5):729–739.
   PubMed Web of Science ®Google Scholar
• Falk RJ, Scheinman J, Phillips G, et al. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med. 1992;326(14):910–915.
   PubMed Web of Science ®Google Scholar
• Maigne G, Ferlicot S, Galacteros F, et al. Glomerular lesions in patients with sickle cell disease. Medicine (Baltimore). 2010;89(1):18–27.
   PubMed Web of Science ®Google Scholar
• Key NS, Derebail VK. Sickle-cell trait: novel clinical significance. Hematology Am Soc Hematol Educ Program. 2010;418-422:2010.
   Google Scholar
• Henderickx MMEL, Brits T, De Baets K, et al. Renal papillary necrosis in patients with sickle cell disease: how to recognize this ‘forgotten’ diagnosis. J Pediatr Urol. 2017;13(3):250–256.
   PubMed Web of Science ®Google Scholar
• Sharpe CC, Thein SL. How I treat renal complications in sickle cell disease. Blood. 2014;123(24):3720–3726.
   PubMed Web of Science ®Google Scholar
• Francis YF, Worthen HG. Hyposthenuria in sickle cell disease. J Natl Med Assoc. 1968;60(4):266–270.
   PubMedGoogle Scholar
• Wolf RB, Kassim AA, Goodpaster RL, et al. Nocturnal enuresis in sickle cell disease. Expert Rev Hematol. 2014;7(2):245–254.
   PubMed Web of Science ®Google Scholar
• Anele UA, Morrison BF, Reid ME, et al. Overactive bladder in adults with sickle cell disease. Neurourol Urodyn. 2016;35(5):642–646.
   PubMed Web of Science ®Google Scholar
• Alvarez O, Zilleruelo G, Wright D, et al. Serum cystatin C levels in children with sickle cell disease. Pediatr Nephrol. 2006;21(4):533–537.
   PubMed Web of Science ®Google Scholar
• Ware RE, Rees RC, Sarnaik SA, et al. Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial. J Pediatr. 2010;156(1):66–70.e1.
   PubMed Web of Science ®Google Scholar
• Aygun B, Mortier NA, Smeltzer MP, et al. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia. Am J Hematol. 2013;88(2):116–119.
   PubMed Web of Science ®Google Scholar
• Vazquez B, Shah B, Zhang X, et al. Hyperfiltration is associated with the development of microalbuminuria in patients with sickle cell anemia. Am J Hematol. 2014;89(12):1156–1157.
   PubMed Web of Science ®Google Scholar
• Aloni MN, Ngiyulu RM, Nsibu CN, et al. Congolese children with sickle cell trait may exhibit glomerular hyperfiltration: a case control study. J Clin Lab Anal. 2017. [Epub ahead of print]
   Google Scholar
• Asnani MR, Lynch O, Reid ME. Determining glomerular filtration rate in homozygous sickle cell disease: utility of serum creatinine based estimating equations. PLoS One. 2013;8(7):e69922.
   PubMed Web of Science ®Google Scholar
• Asnani M, Reid M. Cystatin C: a useful marker of glomerulopathy in sickle cell disease? Blood Cells Mol Dis. 2015;54(1):65–70.
   PubMed Web of Science ®Google Scholar
• Naik RP, Derebail VK, Grams ME, et al. Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans. JAMA. 2014;312(20):2115–2125.
   PubMed Web of Science ®Google Scholar
• McPherson Yee M, Jabbar SF, Osunkwo I, et al. Chronic kidney disease and albuminuria in children with sickle cell disease. Clin J Am Soc Nephrol. 2011;6(11):2628–2633.
   PubMed Web of Science ®Google Scholar
• Guasch A, Navarrete J, Nass K, et al. Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol. 2006;17(8):2228–2235.
   PubMed Web of Science ®Google Scholar
• Bakir AA, Hathiwala SC, Ainis H, et al. Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study. Am J Nephrol. 1987;7(2):110–115.
   PubMed Web of Science ®Google Scholar
• Kramer HJ, Stilp AM, Laurie CC, et al. African ancestry-specific alleles and kidney disease risk in hispanics/latinos. J Am Soc Nephrol. 2017;28(3):915–922.
   PubMed Web of Science ®Google Scholar
• Gosmanova EO, Zaidi S, Wan JY, et al. Prevalence and progression of chronic kidney disease in adult patients with sickle cell disease. J Investig Med. 2014;62(5):804–807.
   PubMed Web of Science ®Google Scholar
• Naik RP, Irvin MR, Judd S, et al. Sickle cell trait and the risk of ESRD in blacks. J Am Soc Nephrol. 2017;28(7):2180–2187.
   PubMed Web of Science ®Google Scholar
• Powars DR, Chan LS, Hiti A, et al. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005;84(6):363–376.
   PubMed Web of Science ®Google Scholar
• Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–1644.
   PubMed Web of Science ®Google Scholar
• Serjeant GR, Serjeant BE, Mason KP, et al. The changing face of homozygous sickle cell disease: 102 patients over 60 years. Int J Lab Hematol. 2009;31(6):585–596.
   PubMed Web of Science ®Google Scholar
• Derebail VK, Nachman PH, Key NS, et al. High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol. 2010;21(3):413–417.
   PubMed Web of Science ®Google Scholar
• Hicks PJ, Langefeld CD, Lu L, et al. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans. Kidney Int. 2011;80(12):1339–1343.
   PubMed Web of Science ®Google Scholar
• Heller P, Best WR, Nelson RB, et al. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med. 1979;300(18):1001–1005.
   PubMed Web of Science ®Google Scholar
• Johnson CS, Giorgio AJ. Arterial blood pressure in adults with sickle cell disease. Arch Intern Med. 1981;141(7):891–893.
   PubMed Web of Science ®Google Scholar
• Grell GA, Alleyne GA, Serjeant GR. Blood pressure in adults with homozygous sickle cell disease. Lancet. 1981;2(8256):1166.
   PubMed Web of Science ®Google Scholar
• Pegelow CH, Colangelo L, Steinberg M, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med. 1997;102(2):171–177.
   PubMed Web of Science ®Google Scholar
• Novelli EM, Hildesheim M, Rosano C, et al. Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease. PLoS One. 2014;9(12):e114309.
   PubMed Web of Science ®Google Scholar
• Asnani M, Serjeant G, Royal-Thomas T, et al. Predictors of renal function progression in adults with homozygous sickle cell disease. Br J Haematol. 2016;173(3):461–468.
   PubMed Web of Science ®Google Scholar
• Lebensburger JD, Cutter GR, Howard TH, et al. Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia. Pediatr Nephrol. 2017.
   Google Scholar
• Gordeuk VR, Sachdev V, Taylor JG, et al. Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol. 2008;83(1):15–18.
   PubMed Web of Science ®Google Scholar
• Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37–47.
   PubMed Web of Science ®Google Scholar
• Drawz P, Ayyappan S, Nouraie M, et al. Kidney disease among patients with sickle cell disease, hemoglobin SS and SC. Clin J Am Soc Nephrol. 2016;11(2):207–215.
   PubMed Web of Science ®Google Scholar
• Noguchi CT, Schechter AN. The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease. Blood. 1981;58(6):1057–1068.
   PubMed Web of Science ®Google Scholar
• Poillon WN, Kim BC, Castro O. Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia. Blood. 1998;91(5):1777–1783.
   PubMed Web of Science ®Google Scholar
• Steinberg MH, Embury SH. Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood. 1986;68(5):985–990.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Kirchner KA, Nicholson R, et al. Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait. J Clin Invest. 1991;88(6):1963–1968.
   PubMed Web of Science ®Google Scholar
• Guasch A, Zayas CF, Eckman JR, et al. Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol. 1999;10(5):1014–1019.
   PubMed Web of Science ®Google Scholar
• Haymann JP, Stankovic K, Levy P, et al. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol. 2010;5(5):756–761.
   PubMed Web of Science ®Google Scholar
• Geard A, Pule GD, Chetcha Chemegni B, et al. Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon. Br J Haematol. 2017. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Piel FB, Patil AP, Howes RE, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010;1:104.
   PubMed Web of Science ®Google Scholar
• Thein SL, Menzel S. Discovering the genetics underlying foetal haemoglobin production in adults. Br J Haematol. 2009;145(4):455–467.
   PubMed Web of Science ®Google Scholar
• Lettre G, Sankaran VG, Bezerra MA, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci US. 2008;105(33):11869–11874.
   PubMed Web of Science ®Google Scholar
• Powars DR, Elliott-Mills DD, Chan L, et al. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med. 1991;115(8):614–620.
   PubMed Web of Science ®Google Scholar
• Lebensburger J, Johnson SM, Askenazi DJ, et al. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia. Am J Hematol. 2011;86(5):430–432.
   PubMed Web of Science ®Google Scholar
• Saraf SL, Shah BN, Zhang X, et al. APOL1, alpha-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia. Haematologica. 2017;102(1):e1–e6.
   PubMed Web of Science ®Google Scholar
• Saraf SL, Zhang X, Shah B, et al. Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy. Haematologica. 2015;100(10):1275–1284.
   PubMed Web of Science ®Google Scholar
• Kormann R, Jannot AS, Narjoz C, et al. Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target. Br J Haematol. 2017. [Epub ahead of print]
   PubMedGoogle Scholar
• Parsa A, Kao WH, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369(23):2183–2196.
   PubMed Web of Science ®Google Scholar
• Dummer PD, Limou S, Rosenberg AZ, et al. APOL1 kidney disease risk variants: an evolving landscape. Semin Nephrol. 2015;35(3):222–236.
   PubMed Web of Science ®Google Scholar
• Ashley-Koch AE, Okocha EC, Garrett ME, et al. MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol. 2011;155(3):386–394.
   PubMed Web of Science ®Google Scholar
• Afenyi-Annan A, Kail M, Combs MR, et al. Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. Transfusion. 2008;48(5):917–924.
   PubMed Web of Science ®Google Scholar
• Nolan VG, Ma Q, Cohen HT, et al. Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor 1B. Am J Hematol. 2007;82(3):179–184.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–1048.
   PubMed Web of Science ®Google Scholar
• Expert Panel NHLBI. Evidence-based management of sickle cell disease. Available from: https://www.nhlbi.nih.gov/sites/www.nhlbi.nih.gov/files/sickle-cell-disease-report.pdf. Published 2014. Accessed on 21 Jun 2017.
   Google Scholar
• Naik RP, Haywood C Jr. Sickle cell trait diagnosis: clinical and social implications. Hematology Am Soc Hematol Educ Program. 2015;2015(1):160–167.
   PubMedGoogle Scholar
• Sasongko TH, Nagalla S, Ballas SK. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Cochrane Database Syst Rev. 2013;3:CD009191.
   Google Scholar
• Aoki RY, Saad ST. Enalapril reduces the albuminuria of patients with sickle cell disease. Am J Med. 1995;98(5):432–435.
   PubMed Web of Science ®Google Scholar
• Foucan L, Bourhis V, Bangou J, et al. A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia. Am J Med. 1998;104(4):339–342.
   PubMed Web of Science ®Google Scholar
• Alvarez O, Miller ST, Wang WC, et al. Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia. Pediatr Blood Cancer. 2012;59(4):668–674.
   PubMed Web of Science ®Google Scholar
• Laurin LP, Nachman PH, Desai PC, et al. Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease. Nephrol Dial Transpl. 2014;29(6):1211–1218.
   PubMed Web of Science ®Google Scholar
• Bartolucci P, Habibi A, Stehle T, et al. Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease. J Am Soc Nephrol. 2016;27(6):1847–1853.
   PubMed Web of Science ®Google Scholar
• Derebail VK, Lacson EK Jr, Kshirsagar AV, et al. Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose. J Am Soc Nephrol. 2015;25(4):819–826.
   Web of Science ®Google Scholar